Fri.Jun 21, 2024

article thumbnail

African vaccine manufacturing initiative aims to provide $1B to local firms over next decade

Fierce Pharma

Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Dise | Amid an influx of efforts to help the African continent claim vaccine sovereignty, a new financing mechanism devised by Gavi, the Vaccine Alliance, the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC) has taken flight.

article thumbnail

FDA Approves Sarepta Gene Therapy, But Only After Top FDA Official Bucks Agency Staff

MedCity News

FDA reviewers concluded the data for Sarepta Therapeutics’ Elevidys were insufficient to show efficacy in the rare muscle disorder Duchenne muscular dystrophy. Peter Marks, the agency’s top biologics official, reviewed the same data and reached a different conclusion. The post FDA Approves Sarepta Gene Therapy, But Only After Top FDA Official Bucks Agency Staff appeared first on MedCity News.

FDA 128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Vertex clinches Trikafta and other cystic fibrosis drug reimbursement deal in England

Fierce Pharma

Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s | Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s National Health Service (NHS).

article thumbnail

AI-Driven Breakthroughs: Transforming Patient Care through Research Consulting

MedCity News

This not only enhances the quality of care and patient satisfaction but also optimizes operational efficiency. The post AI-Driven Breakthroughs: Transforming Patient Care through Research Consulting appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

A closer look at 'friend-shoring' and the drug shortage challenge

Fierce Pharma

In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.< | In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker sits down with Bobby Sheng, the CEO of Bora Pharmaceuticals, to discuss the concept of “friend-shoring” in drug manufacturing.

article thumbnail

The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients

MedCity News

Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions. The post The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients appeared first on MedCity News.

Medical 119

More Trending

article thumbnail

What’s on the Agenda for MedCity INVEST Digital Health in Dallas?

MedCity News

MedCity’s annual INVEST Digital Health conference in Dallas September 18 will delve into innovation at the intersection of AI and drug development, investment trends, consumer-focused diagnostics and validating digital health tools. The post What’s on the Agenda for MedCity INVEST Digital Health in Dallas? appeared first on MedCity News.

111
111
article thumbnail

Gilead’s twice-yearly HIV PrEP 100% effective, says study

pharmaphorum

Twice-yearly lenacapavir injection provides 100% protection from HIV when used as PrEP in cisgender women, says Gilead.

111
111
article thumbnail

New ‘space hairdryer’ to regenerate heart tissue after bypass surgery

PharmaTimes

According to WHO, cardiovascular diseases are responsible for 17.

Medical 106
article thumbnail

Chimps’ self-medication with plants could aid drug discovery

pharmaphorum

Chimps’ self-medication with plants could aid drug discovery Phil.

Medical 105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Knownwell Acquires Competitor to Expand Access to Comprehensive Obesity Care

MedCity News

Knownwell acquired one of its competitors, just six months after announcing its $20 million Series A funding round. The startup, which provides hybrid primary care and metabolic health treatment, bought Alfie Health, an online obesity management clinic with an AI platform that generates personalized recommendations for weight management. The post Knownwell Acquires Competitor to Expand Access to Comprehensive Obesity Care appeared first on MedCity News.

article thumbnail

NWEH says module cuts side effect reporting burden in trials

pharmaphorum

NWEH launches software that takes legwork out of serious adverse event reporting in clinical trials and could reduce costs.

article thumbnail

KCL’s mini liver model promises more effective drug testing method

PharmaTimes

The method provides a more accurate and ethical approach to drug testing for medicines

Ethics 102
article thumbnail

Pharma Pulse 6/21/24: Global Mortality and Disability from Type 1 Diabetes Have Decreased, What Leaders of Effective Teams Know & more

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Sustainable innovation for patients, people, and planet

pharmaphorum

Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at Chiesi UK & Ireland, about how partnerships between the NHS and pharma industry can support the journey to more sustainable practices, from R&D and drug reimbursement to medicines and recycling.

article thumbnail

Gilead small molecule demonstrates strong capability for HIV prevention

European Pharmaceutical Review

Gilead Sciences ’ twice-yearly injectable HIV-1 capsid inhibitor enabled 100 percent efficacy for investigational use of HIV prevention in cisgender women. This is according to interim analysis topline results of the Phase III PURPOSE 1 trial. Lenacapavir showed superiority to once-daily oral Truvada ® (emtricitabine 200mg and tenofovir disoproxil fumarate 300mg; F/TDF) and background HIV incidence (bHIV).

Safety 98
article thumbnail

WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe

Pharmaceutical Technology

Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers of their diabetes and weight loss drugs.

98
article thumbnail

What’s Missing from Value-Based Care Convos, According to Providence Health Plan’s CEO

MedCity News

In a recent interview, Don Antonucci, president and CEO of Providence Health Plan, spoke about how the industry needs to improve value-based care. The post What’s Missing from Value-Based Care Convos, According to Providence Health Plan’s CEO appeared first on MedCity News.

64
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments

Pharmaceutical Technology

Trial investigators anticipate that the FDA will decide on approval for linvoseltamab in relapsed/refractory multiple myeloma by the end of 2024.

FDA 98
article thumbnail

BENEFIT Trial Results Show Quadruplet Regimen for NDMM TI May Require Weighing Efficacy vs Safety

Pharmacy Times

The quadruplet regimen added bortezomib to the current standard of care, which is a triplet regimen of isatuximab, lenalidomide, and dexamethasone for patients with transplant-ineligible, newly diagnosed multiple myeloma (NDMM TI).

Safety 55
article thumbnail

Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio

Pharmaceutical Technology

The company has also raised $130.7m in a private placement, which along with Tectonics' previous cash reserves.

64
article thumbnail

FDA Commissioner Says the United States Is Failing the Type 2 Diabetes Epidemic

Pharmacy Times

With improved technology and innovations for diabetes, it is essential for health care providers and health agencies to collaborate to combat rising rates of diabetes.

FDA 55
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

How People Define Revenue Operations (RevOps)

Clear Pivot

An organization that’s not looking for ways to get ahead is already falling behind. Maturing tech has given rise to a new approach to getting ahead that you might (or might not) know as Revenue Operations (RevOps). It’s critical to making every part of a business work together better, so successful growth depends on it. But being a newly-emerging field, RevOps is still in the process of being defined.

52
article thumbnail

Scott Burrows, Inspirational Business Keynote Speaker, Turing Setbacks into Comebacks: My Journey of Vision, Mindset, and Grit

Scott Burrows

In a world filled with stories of resilience and triumph, my journey stands as a testament to the power of determination and unwavering optimism. From the heights of athletic glory to the depths of life-altering challenges, I have navigated a path guided by three fundamental principles: vision, mindset, and grit. Embracing Vision: Seeing Beyond Circumstances My story began on the football field, where I excelled as a star wide receiver for Florida State University.

article thumbnail

Cultural Transformations a Necessity to Support Complex Therapeutics Through Development and Manufacturing

PharmaTech

President and CEO of Pharmaceutics International, Inc. (Pii), John Fowler, reacts to the agility and flexibility needed to support the development and manufacture of today's complex biotherapeutics.

article thumbnail

Phase III Trial Data Show Lenacapavir Demonstrated 100% Efficacy Preventing HIV in Cisgender Women

PharmExec

Results of the PURPOSE 1 trial indicated that a twice-yearly injection of lenacapavir outperformed the once-daily oral Truvada preventing HIV in cisgender women.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Sarepta’s Elevidys secures US label expansion for DMD

Pharmaceutical Technology

Sarepta’s stock rose by over 36% following the positive news of the FDA expanding the gene therapy’s US label.

FDA 52
article thumbnail

Abzena, Argonaut Form Drug Development Alliance

Pharmaceutical Commerce

The partnership will offer an end-to-end manufacturing solution for biopharma companies.

article thumbnail

FDA Expands Approval of Sarepta Therapeutics’ Elevidys for the Treatment of Duchenne Muscular Dystrophy

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52
article thumbnail

Navigating Market Access Hurdles

Pharmaceutical Commerce

Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A